Parkinson’s disease (PD) is the second most common neurodegenerative disorder. First noticiable symptoms in PD are those related to an altered movement control. Current PD treatments temporally revert the symptoms, but they do not prevent disease’s progression.
At the beginning of the treatment, the antiparkinsonian effect of the medication is very evident and symptoms may completely disappear for hours; however, as disease progresses, motor fluctuations appear. Collecting precise information on the temporal course of fluctuations is essential for tailoring an optimal therapy in PD patients and is one of the main parameters in clinical trials.
Rempark European project
The goal of the REMPARK project was to develop a Personal Health System, featuring closed loop detection, with response and treatment capabilities, for the improved management of Parkinson’s disease patients.
Sense4Care develops a Parkinson Holter using part of the Rempark results based on a knowledge transfer agreement with the Universitat Politècnica de Catalunya.